Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.

Burns : journal of the International Society for Burn Injuries - 1 Mar 2005

Neely Alice N, Holder Ian A, Wiener-Kronish Jeanine P, Sawa Teiji

Abstract excerpt

The type III secretion system consists of secreted exoproducts and structural components, such as PcrV, and this system plays an important role in the virulence of Pseudomonas aeruginosa in burned hosts. The purpose of this study was to determine if passive anti-PcrV treatment would protect burned mice from fatal P. aeruginosa challenge, and to determine the type III exoproduct phenotype of the P. aeruginosa used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Antigens, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bacterial Toxins

Share to Immunization, Passive

Share to Immunoglobulin G

Share to Pore Forming Cytotoxic Proteins

Share to Pseudomonas Infections

Source

Identifiers

PMID: 15683685
DOI: 10.1016/j.burns.2004.09.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.PMID 15683685Read ↗

Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.Semantic proximity Read ↗

An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates.Semantic proximity Read ↗

Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa.Semantic proximity Read ↗

Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.Semantic proximity Read ↗

Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.Semantic proximity Read ↗

Alveolar Response toPseudomonas aeruginosa: Role of the Type III Secretion SystemSemantic proximity Read ↗

Mucosal-adapted bacteriophages as a preventive strategy for a lethal Pseudomonas aeruginosa challenge in miceSemantic proximity Read ↗

The Pseudomonas aeruginosa type III secretion system has an exotoxin S/T/Y independent pathogenic role during acute lung infection.Semantic proximity Read ↗

Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns.Semantic proximity Read ↗

A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.Semantic proximity Read ↗

Multicomponent <i>Pseudomonas aeruginosa</i> vaccines eliciting Th17 cells and functional antibody responses confer enhanced protection against experimental acute pneumonia in miceSemantic proximity Read ↗

Type III secretion system of <i>Pseudomonas aeruginosa</i> affects mucin gene expression via NF-κB and AKT signaling in human carcinoma epithelial cells and a pneumonia mouse modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.